{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Whitehouse Station",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88867",
      "recalling_firm": "MERCK SHARP & DOHME CORP",
      "address_1": "1 Merck Dr",
      "address_2": "N/A",
      "postal_code": "08889-3400",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0093-2022",
      "product_description": "Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01",
      "product_quantity": "76,163 vials",
      "reason_for_recall": "Presence of Particulate Matter: Identified as Glass Particles",
      "recall_initiation_date": "20211019",
      "center_classification_date": "20211103",
      "termination_date": "20230725",
      "report_date": "20211110",
      "code_info": "Lot #: 934778, Exp. Date Jun 2022"
    }
  ]
}